Vimarsana
Biggest News Aggregation in the World

Fruergaard Jorgensen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Fruergaard Jorgensen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Fruergaard Jorgensen Today - Breaking & Trending Today

BLOOMBERG Bloomberg Surveillance July 13, 2024 - Vimarsana News

BLOOMBERG Bloomberg Surveillance July 13, 2024

Executive later. Another busy day. A lot of people were talking about in the virtual newsroom that we have created around the world that we cant quite remember whether it is tuesday, wednesday, or thursday. A lot of the focus is on what your markets are doing. This is your data, euro area, april services pmi coming up at 12. The preliminary figure was a touch below that. That Services Data coming in at 12 instead of the preliminary 11. 7. That is a little bit better than expected. I am looking forward to the ofexecutive of com campari. Look at renminbi. President trump continuing to push the r...

BLOOMBERG Bloomberg Markets European Open February 1, 2018 - Vimarsana News

BLOOMBERG Bloomberg Markets European Open February 1, 2018

Soon. In the fast lane, aston martin plans a fiveyear trade and investment drive in china worth over 600 Million Pounds. We will speak to the ceo, next. We are less than a halfhour from the start of european trading. Take a look at futures right now. We are seeing gains across the board on the major indexes with the exception of the ibex sorry, the ftse mib and stockholm. Here on the board, ftse futures gaining 0. 4 , dax futures up 0. 5 . Lets start with some of the earnings this morning. Roche expects sales growth to slow this year. It is counting on new drugs in the pipeline to offset reven...

Novo Nordisk Plans to Cut US Price for Blockbuster Obesity Drug Wegovy - Vimarsana News

Novo Nordisk Plans to Cut US Price for Blockbuster Obesity Drug Wegovy

Sales of Wegovy more than doubled in the first quarter year-on-year, to $1.3 billion.

Novo Nordisk lifts 2024 outlook on weight-loss drug demand - Vimarsana News

Novo Nordisk lifts 2024 outlook on weight-loss drug demand

Danish pharma giant Novo Nordisk lifted its 2024 outlook on Thursday and delivered better-than-expected first quarter profits as the company races to boost...

Weight-loss Drug Maker Novo Nordisk's Profits Soar Further - Vimarsana News

Weight-loss Drug Maker Novo Nordisk's Profits Soar Further

The drugmaker increased its market share of the diabetic treatment market by 1.8 percentage points and now has a 34-percent share of the market.